Victory Capital Management Inc Neoleukin Therapeutics, Inc. Transaction History

Victory Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$9.23 - $13.12 $202,017 - $287,157	-21,887 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$11.26 - $15.78 $8,377 - $11,740	-744 Reduced 3.29%	21,887 $269,000
Q4 2020 Feb 01, 2021	BUY	$10.17 - $14.56 $50,280 - $71,984	4,944 Added 27.95%	22,631 $319,000
Q3 2020 Nov 09, 2020	BUY	$9.68 - $17.01 $48,419 - $85,084	5,002 Added 39.43%	17,687 $212,000
Q2 2020 Aug 07, 2020	BUY	$9.95 - $17.05 $126,215 - $216,279	12,685 New	12,685 $211,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.